The Latest Breaking News from Merck

Merck & Co. has underperformed the healthcare sector this year, but Wall Street analysts are bullish about the stock prospects.

With advancements in biomedical sciences and promising drug pipelines, the healthcare industry is set for substantial growth in the coming years. Hence, investors might find opportunities in adding UnitedHealth Group (UNH), Merck & Co. (MRK), and Pfizer (PFE) to their portfolios for potential gains this year. Read on….

The stock market took a bearish turn amid economic fears. Apple and Meta had strong results, while AI spending remains robust.

Stocks are down despite higher consumer confidence.

Stocks fell Tuesday as the Fed meeting got underway. Microsoft fell ahead of earnings while Merck and Proctor & Gamble plunged after results.

The Dow Jones rose Tuesday, as the Federal Reserve's meeting kicks off. Microsoft earnings are up next on the stock market today.

Merck stock skidded Tuesday on full-year guidance that lagged expectations despite a strong second-quarter showing from Keytruda.

Vaccinations have provided significant protection for the public against infectious diseases. However, there was a modest decrease in support in 2023 nationwide for vaccine requirements for children to attend public schools.

No one knows when the next S&P 500 crash will hit. But everyone should know which stocks to watch out for.